| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.27 | 5e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.09 |